Target intelligence / Profile preview

Hantaan virus envelope glycoprotein Gn (Gn)

Target
Gn
Molecular classification
Viral envelope glycoprotein, Type I transmembrane protein
01

Overview

Hantaan virus envelope glycoprotein Gn is a critical structural component of the Hantaan virus, which is the primary cause of Hemorrhagic Fever with Renal Syndrome (HFRS) in Eurasia [3, 11]. It is encoded by the M segment of the viral genome and undergoes post-translational cleavage to form a mature protein that assembles into heterotetrameric spikes with the Gc glycoprotein on the viral envelope [2, 8]. These spikes are responsible for the initial attachment of the virus to host cell receptors, including β3 integrins and C1QBP, thereby facilitating viral entry via clathrin-mediated endocytosis [2, 15]. Gn also plays a significant role in the assembly and budding of new virions by interacting with the viral nucleocapsid protein [2, 3]. As the primary target for the host's neutralizing antibody response, Gn is a major focus for the development of vaccines and therapeutic monoclonal antibodies [11, 14]. Experimental treatments, such as the monoclonal antibodies HTN-Gn1 and MIB22, aim to neutralize the virus by blocking its ability to infect host cells [14, 15].

Other names
Glycoprotein NGlycoprotein G1G1Gn proteinHantaan virus G1 protein
02

Mechanism of action

Neutralization of viral infection by blocking attachment to host cell receptors and inhibiting viral entry and membrane fusion.

03

Biological functions

Viral attachmentReceptor bindingViral entryVirus assemblyVirus budding
04

Disease associations

Hemorrhagic fever with renal syndromeInfection
05

Safety considerations

Viral immune escapeAntibody-dependent enhancement (ADE)High sequence variability
06

Interacting drugs

HTN-Gn1

5 more in the full profile.

07

Biomarkers

Anti-Gn neutralizing antibodiesHantaan virus RNA

Beyond the preview

Go deeper on Hantaan virus envelope glycoprotein Gn (Gn).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hantaan virus envelope glycoprotein Gn (Gn).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call